Search results for: type 1 diabetes

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms

Emine Atac, MD, and John H. Stone, MD, MPH | January 1, 2013

What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

Vanessa Caceres | November 1, 2012

Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

Information on new approvals and medication safety rheumatologists need to know

Eliza F. Chakravarty, MD, MS | October 1, 2012

A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

information on new approvals and medication safety

First impressions and presumptions can lead us astray if we don’t pay attention.

David Holzman | July 31, 2012

A new study suggests that a small abnormality in an immunity gene can alter the gut flora in a way that induces development of rheumatoid arthritis.

Kurt Ullman | June 10, 2012

Although no cure, assistive devices can have an impact on pain of arthritis in the lower extremities